CareFirst BlueCross BlueShield does cover GLP-1 medications, but how you get one depends on why it’s prescribed and which CareFirst plan you carry. For most commercial and federal plans, a GLP-1 prescribed for weight management has to run through a dedicated program called Noom Med. A GLP-1 prescribed for type 2 diabetes does not.1CareFirst. FAQs Noom Med
Weight Loss and Diabetes Follow Different Paths
This split matters because the same molecule can sit on either side of it. Semaglutide is sold as Ozempic for type 2 diabetes and as Wegovy for weight loss. If your prescription is for diabetes, your regular doctor can write it and your pharmacy benefit processes it under the usual rules. If it’s for weight management, the prescription must come from the Noom Med Care Team, and a script written by your primary care doctor or any outside provider will be denied at the pharmacy.2CareFirst. Noom Med Member Flier FAQs
Members already taking a GLP-1 for weight loss when they become eligible are expected to transfer their care to the Noom Med team, which reviews the existing medication and incorporates it into a new treatment plan.
What Noom Med Is
Noom Med is a clinically supervised weight loss program operated by Noom, Inc. and offered through CareFirst WellBeing. The program itself costs the member nothing extra. The medications prescribed through it still carry whatever cost-sharing applies under your pharmacy benefit, which varies by plan.1CareFirst. FAQs Noom Med
Who Qualifies
To enroll in Noom Med, you must be between 18 and 80 years old and meet at least one of these clinical thresholds:3CareFirst. Noom Med Enhanced Weight Management Support
- A BMI of 30 or higher, which qualifies on its own.
- A BMI of 27 or higher with at least one qualifying comorbidity: high blood pressure, type 2 diabetes, high cholesterol, osteoarthritis or other joint and muscle issues, liver disease, heart disease, polycystic ovary syndrome, or low testosterone.
Several groups are excluded entirely. You cannot participate if you are pregnant, breastfeeding, or planning a pregnancy within six months. The program is also closed to members with Type 1 diabetes, members currently using insulin, and members with an active eating disorder such as binge eating disorder, bulimia, or anorexia. Anyone carrying Medicaid as a primary or secondary insurance is excluded.4CareFirst. Noom Med Enhanced Weight Management Support
One exclusion is specific to GLP-1s. Members with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia Type 2 cannot receive a GLP-1 through the program, though they may still qualify for an oral weight management medication through Noom Med.3CareFirst. Noom Med Enhanced Weight Management Support
How You Actually Get the Prescription
The process runs through the Noom app and takes several steps.5CareFirst. FAQs Noom Med New members start in the CareFirst WellBeing portal and complete an online health assessment. Existing Noom users can check the app for a qualification message.
After the assessment, you complete blood work: a comprehensive metabolic panel, A1c, thyroid stimulating hormone test, and lipid panel. CareFirst covers these labs, typically run at Quest or Labcorp. If you’ve had the same tests within the past six months, you can upload those results instead. Virginia residents also need a blood pressure and pulse reading taken during a video consultation, and the program sends a complimentary blood pressure cuff for that purpose.2CareFirst. Noom Med Member Flier FAQs
Based on the clinical review, the Noom Med Care Team places each member on one of three paths: enhanced lifestyle support, an oral anti-obesity medication, or a GLP-1. A video visit finalizes the plan. If a GLP-1 is prescribed, Noom Med sends the script directly to a local pharmacy or to mail order.
How Coverage Varies by Plan
Federal Employee and Postal Service Plans
CareFirst’s Federal Employees Health Benefits and Postal Service Health Benefits plans use Noom Med as the designated route for GLP-1 weight management coverage, under the eligibility rules above.4CareFirst. Noom Med Enhanced Weight Management Support Copay and coinsurance for the medication itself depend on the plan option; CareFirst points members to its online drug calculator for a specific drug’s cost.1CareFirst. FAQs Noom Med
DC Government Employees
DC government employees gained Noom Med coverage effective January 1, 2025, including both anti-obesity medications and GLP-1s. Eligibility is limited to active DC government employees and retirees under age 65 who were hired after October 1, 1987. As on other plans, the prescription must come from the Noom Med Care Team.2CareFirst. Noom Med Member Flier FAQs
Maryland State Employees
Maryland state employees covered by CareFirst can reach Noom through CareFirst WellBeing, which includes “GLP-1 Companion” resources for members already prescribed a GLP-1 for weight loss. An online assessment determines eligibility.6CareFirst. 2025 Health Plan Guide
Employer Group Plans
Employer-sponsored CareFirst coverage is not uniform. Some employer plans exclude weight loss medications outright. CareFirst’s prescription drug materials note that “some plans may exclude coverage for certain categories of drugs, such as those for weight loss,” and direct members to their benefit documents or HR department to confirm.7MyRxToolkit. Prescription Drugs If your employer plan carries that exclusion, Noom Med does not override it.
CareFirst Medicaid (CHPMD)
CareFirst’s Medicaid plan, the Community Health Plan Maryland, is a different animal. Medicaid members are explicitly excluded from Noom Med.3CareFirst. Noom Med Enhanced Weight Management Support CHPMD instead applies formal drug-by-drug coverage criteria. Wegovy requires prior authorization and is covered only in two narrow situations: established atherosclerotic cardiovascular disease in a member with a BMI of 27 or higher, or noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis. The cardiovascular indication requires a cardiologist as prescriber or consultant; the liver indication requires a gastroenterologist or hepatologist.8CareFirst. Coverage of Wegovy for Overweight or Obese Adults With Cardiovascular Disease CHPMD maintains a separate coverage notice for Zepbound.9CareFirst. Pharmacy Additional Resources
Prior Authorization and Step Therapy
CareFirst uses prior authorization and step therapy across its formularies. Prior authorization means the plan has to approve the prescription before the pharmacy can fill it. Step therapy means you have to try a lower-cost drug first before the plan will cover a more expensive one.10CareFirst. Understanding Drug Coverage CareFirst doesn’t publish a single consolidated list of which GLP-1s trigger these requirements. To find out for your plan, use the online drug search tool or review the prior authorization and step therapy criteria for your specific plan.11CareFirst. Drug Management Programs
You and your prescriber can request an exception if alternative drugs would be ineffective or cause adverse effects. New members on a drug that requires prior authorization may qualify for a one-time 30-day transition fill within their first 90 days of enrollment.
If Your Prescription Gets Denied
Coverage disputes over GLP-1s have reached federal court. In Hamburger v. CareFirst BlueCross BlueShield, a federal employee challenged CareFirst and its pharmacy benefit manager, CaremarkPCS Health, after his Zepbound prescription for obstructive sleep apnea was denied. He argued that FDA approval of Zepbound for sleep apnea should move it outside the weight-loss drug category. U.S. District Judge Trevor N. McFadden disagreed in June 2026, finding that the plan’s exclusion for “prescription drugs for weight loss” applied because the FDA approval required the patient to have obesity and relied on weight loss as the therapeutic mechanism. The case was dismissed.12GovInfo. Hamburger v. CareFirst BlueCross BlueShield
CareFirst has also been named in broader class-action litigation. Bloomberg Law reports that lawsuits allege CareFirst and pharmacy benefit managers breached ERISA fiduciary duties by discriminating against people with obesity and denying Zepbound coverage. Some plaintiffs allege insurers favored Wegovy over Zepbound because of higher manufacturer rebates, which they contend violates ERISA’s prohibited transaction rules.13Bloomberg Law. Weight-Loss Drug Suits Test Health Insurer Coverage Decisions
If your own prescription is denied, the first step is to confirm the reason: whether the drug is excluded from your plan, whether prior authorization or step therapy was missing, or whether the prescription came from someone other than the Noom Med Care Team. Each has a different fix.